Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Neda A. Moatamed, M.D.
Neda A. Moatamed, M.D.

Specialty:

Pathology

General Information:

Gender:
Female
Language(s):
English, Farsi

Affiliation(s):

Assistant Professor, Department of Pathology and Laboratory Medicine
Member, JCCC Signal Transduction and Therapeutics Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center

Education:

Fellowship:
Pathology, UCLA School of Medicine, 2005 - 2006
Cytopathology, LAC + USC Medical Center, 2004 - 2005
Surgical Pathology, LAC + USC Medical Center, 2003 - 2004
Residency:
Anatomic and Clinical Pathology, LAC + USC Medical Center, 2000 - 2003
Internship:
Pathology, LAC + USC Medical Center, 1999 - 2000
Medical Degree:
M.D., Iran University of Medical Sciences, 1996

Certification(s):

Medical Board Certification(s):
Cytopathology, American Board of Pathology, 2005
Anatomic Pathology and Clinical Pathology, American Board of Pathology, 2004

Contact Information:

Phone:
(310) 825-0581
Email:

Scientific Interest(s):

Dr. Neda Moatamed is interested in understanding the clinical and pathological behavior of gynecologic neoplasms and breast cancers. She is also interested in studying the molecular and genetic pathways in breast and gynecological tumors.

Selected Cancer-Related Publications:

Moatamed NA, Le LT, Levin MR, Govind R, Apple SK. In Papanicolaou smears, benign appearing endometrial cells bear no significance in predicting uterine endometrial adenocarcinomas. Diagn Cytopathol. 2013 Apr;41(4):335-41. doi: 10.1002/dc.21863. Epub 2011 Nov 18.

Moatamed NA, Apple SK, Bennett CJ, Aronson WJ, Klisak I, Shirley CC, Moatamed F. Exclusion of the uniform tetraploid cells significantly improves specificity of the urine FISH assay. Diagn Cytopathol. 2013 Mar;41(3):218-25. doi: 10.1002/dc.21831. Epub 2011 Oct 11.

Moatamed NA, Nanjangud G, Pucci R, Lowe A, Shintaku IP, Shapourifar-Tehrani S, Rao N, Lu DY, Apple SK. Effect of ischemic time, fixation time, and fixative type on HER2/neu immunohistochemical and fluorescence in situ hybridization results in breast cancer. Am J Clin Pathol. 2011 Nov;136(5):754-61. doi: 10.1309/AJCP99WZGBPKCXOQ.

Apple S, Pucci R, Lowe AC, Shintaku I, Shapourifar-Tehrani S, Moatamed N. The effect of delay in fixation, different fixatives, and duration of fixation in estrogen and progesterone receptor results in breast carcinoma. Am J Clin Pathol. 2011 Apr;135(4):592-8.

Ohsie SJ, Moatamed NA, Chang HR, Apple SK. Heterotopic breast tissue versus occult metastatic carcinoma in lymph node, a diagnostic dilemma. Ann Diagn Pathol. 2010 Aug;14(4):260-3. Epub 2009 Sep 19.